Skip to content

Pacira Belgium: what changed

BE 0742.926.265NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€1,682
2024 · €23,953-€25,635
Equity
€1.9m
2024 · €1.9m-€1,682
Cash
€139,152
2024 · €73,098+€66,054
Balance sheet total
€3.0m
2024 · €2.9m+€136,351

Largest movements

2024 to 2025
Assets
  • Cash +€66,054

    up €66,054 (+90.4%), from €73,098 to €139,152

    mainly Other debts (+€145,598) and Provisions (+€19,667)

  • Receivables within one year +€57,682

    up €57,682 (+2.1%), from €2.8m to €2.8m

    of which Trade receivables: +€56,296

Equity and liabilities
  • Other debts +€145,598

    up €145,598 (+17.2%), from €845,055 to €990,652

Income statement
  • Gross operating margin -€53,118

    down €53,118 (-21.8%), from €244,207 to €191,089

  • Staff costs -€40,335

    down €40,335 (-19.6%), from €205,478 to €165,143

  • Provisions +€19,667

    new in 2025: €19,667

  • Taxes -€11,178

    down €11,178 (-78.6%), from €14,229 to €3,052

  • Depreciation +€2,559

    new in 2025: €2,559

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €23,953
Gross operating margin -€53,118
Staff costs +€40,335
Depreciation -€2,559
Provisions -€19,667
Other operating charges +€174
Financial income -€711
Financial charges -€1,267
Taxes +€11,178
Result 2025 -€1,682
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€80,878
Investment -€14,824
Financing €0
Cash 2024 €73,098
Net result for the year -€1,682
Depreciation +€2,559
Receivables within one year -€57,682
Deferred charges and accrued income -€350
Provisions +€19,667
Trade debts -€2,946
Tax, wage and social debts -€24,284
Other debts +€145,598
Investment in fixed assets (net) -€14,824
Cash 2025 €139,152
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,864,436 €3,000,787 +€136,351 +4.8%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €2,180 €14,445 +€12,265 +563%
Tangible fixed assets 22/27 €0 €12,265 +€12,265
Furniture and vehicles 24 €0 €12,265 +€12,265
Financial fixed assets 28 €2,180 €2,180 = 0.0%
Current assets 29/58 €2,862,256 €2,986,342 +€124,086 +4.3%
Amounts receivable within one year 40/41 €2,789,013 €2,846,695 +€57,682 +2.1%
Trade receivables 40 €2,786,008 €2,842,304 +€56,296 +2.0%
Other amounts receivable 41 €3,005 €4,391 +€1,386 +46.1%
Cash at bank and in hand 54/58 €73,098 €139,152 +€66,054 +90.4%
Deferred charges and accrued income 490/1 €144 €495 +€350 +242%
Total equity and liabilities 10/49 €2,864,436 €3,000,787 +€136,351 +4.8%
Equity 10/15 €1,946,866 €1,945,183 -€1,682 -0.1%
Contributions 10/11 €1,800,000 €1,800,000 = 0.0%
Profit (loss) carried forward 14 €146,866 €145,183 -€1,682 -1.1%
Provisions and deferred taxes 16 - €19,667 +€19,667
Provisions for liabilities and charges 160/5 - €19,667 +€19,667
Other liabilities and charges 164/5 - €19,667 +€19,667
Amounts payable 17/49 €917,570 €1,035,937 +€118,367 +12.9%
Amounts payable within one year 42/48 €917,570 €1,035,937 +€118,367 +12.9%
Trade debts 44 €17,579 €14,632 -€2,946 -16.8%
Suppliers 440/4 €17,579 €14,632 -€2,946 -16.8%
Taxes, remuneration and social security 45 €54,937 €30,653 -€24,284 -44.2%
Taxes 450/3 €37,039 - -€37,039
Remuneration and social security 454/9 €17,898 €30,653 +€12,754 +71.3%
Other amounts payable 47/48 €845,055 €990,652 +€145,598 +17.2%
Remuneration, social security and pensions 62 €205,478 €165,143 -€40,335 -19.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €2,559 +€2,559
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - €19,667 +€19,667
Other operating charges 640/8 €235 €61 -€174 -74.0%
Gross operating margin 9900 €244,207 €191,089 -€53,118 -21.8%
Operating profit (loss) 9901 €38,494 €3,659 -€34,835 -90.5%
Financial income 75/76B €791 €80 -€711 -89.9%
Recurring financial income 75 €791 €80 -€711 -89.9%
Financial charges 65/66B €1,103 €2,370 +€1,267 +115%
Recurring financial charges 65 €1,103 €2,370 +€1,267 +115%
Profit (loss) for the period before taxes 9903 €38,182 €1,369 -€36,813 -96.4%
Income taxes 67/77 €14,229 €3,052 -€11,178 -78.6%
Profit (loss) for the period 9904 €23,953 -€1,682 -€25,635
Profit (loss) for the period to be appropriated 9905 €23,953 -€1,682 -€25,635

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.0m to €1.0m

Midpoint €1.0m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €1.9m
Capitalised earnings €110,014 to €154,020
Indication €1.0m to €1.0m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,945,183
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.9m

Capitalised earnings

net result for the year (9904)
2025
-€1,682
2024
€23,953
2023
€23,935
2022
€55,844
2021
€57,214
Average result
€15,402
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€110,014 / €128,350 / €154,020

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.